As Chief Executive Officer of Slade Pharmacy and Slade Health, Russell leads all aspects of pharmacy, compounding and retail operations. His leadership is defined by a strong focus on clinical excellence, innovation and patient-centred care.
Russell has worked in senior management roles across both public and private sectors in Australia and the United Kingdom. He is a former Board Director of the Pharmaceutical Society of Australia (PSA) and served as Chair of the Advanced Pharmacy Australia (AdPha) Leadership and Management Committee. He holds a Bachelor of Pharmacy and postgraduate qualifications in clinical pharmacy and management (MBA) from Curtin University and Nottingham University Business School.
Since joining Icon Group, Russell has held numerous leadership roles, including Director of the Pharmacy Practice Unit, General Manager of Pharmacy Services in Western Australia, and State Manager (WA & SA) for Icon Cancer Centre. His wide-ranging experience across cancer care and pharmacy provides a comprehensive perspective on operations and multidisciplinary clinical quality.
Appointed CEO in 2025, Russell has overseen digital transformation, commercial excellence, and sustainable growth across Slade’s pharmacy and compounding services. He is a hands-on leader committed to expanding opportunities for pharmacy and compounding professionals, supporting workforce development, and ensuring patients and hospital partners continue to receive the highest-quality care. In addition to his role as CEO, Russell is a pharmacy proprietor, reflecting his commitment to guiding the long-term success of Slade.